|
|
|
|
|
FREMONT, CA, 2023年3月28日 - (亞太商訊) - Q'Apel Medical Inc. was granted the CE Mark under MDR for Walrus, their U.S. market-leading Balloon Guide Catheter (BGC) utilized in treating patients suffering an acute ischemic stroke. The Walrus BGC has been utilized by Neuro Interventional physicians since 2019 and has successfully treated over 20,000 patients in the United States.
The Walrus BGC is a unique development in the field of Mechanical Thrombectomy procedures. It provides physicians with not only the known benefits of BGC use clinically, but unique to Walrus, superior ease of use in preparation in these urgent procedures. Importantly, Walrus enables the physicians to navigate the catheter into a more distal location easily and safely compared to other systems, which is associated with improved patient outcomes from stroke.
"The anticipation of Walrus in our international markets has been enormous, and we look forward to the same performance and loyalty around Walrus we have been fortunate to experience in the United States," said King Nelson, Q'Apel Medical's CEO.
"We are thrilled to be entering the EU and other international markets with Walrus and providing more physicians in more countries the unparalleled performance of our flagship catheter. This CE Mark certification represents a significant growth milestone for Q'Apel Medical providing access to new markets," commented Jodie Fam, Chief Marketing Officer & GM International.
About Q'Apel Medical
Q'Apel Medical designs highly innovative technologies for neurovascular interventions and unmet clinical needs. Q'Apel's portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. By blending flow control, trackability, support, and access into one revolutionary solution, Walrus offers truly unmatched functionality. The Wahoo Hybrid Access System and Armadillo Radial Access System are dual-mode catheters and part of the SelectFlex(TM) Family of Neurovascular Catheters. These devices feature two distinct operational modes, allowing physicians to easily switch modes at any point during a clinical case and reducing the need for multiple catheters in challenging procedures.
Media Contact:
Jodie Fam
415 244 9885
+44 7500702108
jfam@qapelmedical.com
info@qapelmedical.com
www.qapelmedical.com
Contact Information
Jodie Fam
Chief Marketing Officer & GM International
jfam@qapelmedical.com
4152449885
SOURCE: Q'Apel Medical Inc.
話題 Press release summary
部門 制药及生物技术, 健康与医药
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network
|
|
|
|
|
|
 |
|
Latest Press Releases
Toyota Launches New RAV4 (PHEV) in Japan
Thursday, February 19, 2026 6:25:00 PM
|
|
|
Osaka Hospital launches project to safely utilize generative AI for healthcare workforce improvements
Thursday, February 19, 2026 11:12:00 AM
|
|
|
Asia's Protein Buyers Still Trail Global Best Practice -- But Momentum is Building, New ARE Benchmark Finds
Feb 19, 2026, 11:02 HKT/SGT
|
|
|
CDAO Sydney 2026 Announces Two-Day, Co Located Event Series Uniting Australia's Senior Data & AI Leaders
Feb 18, 2026, 17:17 HKT/SGT
|
|
|
India's Power Transition Creates Clear Utility Divide
Feb 18, 2026, 16:00 HKT/SGT
|
|
|
MHI Machinery Systems Participates in Ramp Merging Support Demonstration Experiment for Autonomous Vehicles on the Tokyo Metropolitan Expressway
Wednesday, February 18, 2026 2:37:00 PM
|
|
|
IDC MarketScape names Hitachi Energy a Leader in Asset Performance Management for Worldwide Utilities
Wednesday, February 18, 2026 9:51:00 AM
|
|
|
Fujitsu named to FORTUNE Magazine's list of 'World's Most Admired Companie's for eighth year running
Wednesday, February 18, 2026 9:41:00 AM
|
|
|
Kraft Heinz, Braskem, and Tenaris to headline OMP Conference Sao Paulo 2026
Feb 17, 2026, 22:00 HKT/SGT
|
|
|
Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR Dietary Supplement
Feb 17, 2026, 21:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
